 |  |
| ||||
Volume 12(Suppl 2); November 2004 Preface 26th Congress of the European Society of Cardiology PMCID: PMC2497028 Hot Lines Hot line I: Prevention and medical treatment: Munich, 29 August 2004 PMCID: PMC2497009 Hot line II: Acute coronary syndromes/medical treatment II: Munich, 29 August 2004 PMCID: PMC2497025 Hot line III: Inflammation in coronary disease: Munich, 30 August 2004 PMCID: PMC2497015 Main Sessions Evidence-based clinical application of noninvasive imaging: Munich, 29 August 2004 PMCID: PMC2497018 Genetic tools in cardiovascular disease — what should the clinician know?: Munich, 29 August 2004 PMCID: PMC2497008 How to manage the symptomatic patient with atrial fibrillation: Munich, 30 August 2004 PMCID: PMC2497019 INTERHEART — a global study of risk factors for acute myocardial infarction in 52 countries: Munich, 29 August 2004 PMCID: PMC2497021 Management of the asymptomatic patient with valve disease: from guidelines to practice: Munich, 30 August 2004 PMCID: PMC2497024 Cell therapy — the genie is out of the tissue culture bottle: Munich, 30 August 2004 PMCID: PMC2497014 Diabetes Tracks Diabetes and the heart — the Euro Heart Survey on the diabetic state of patients with coronary artery disease: Munich, 29 August 2004 PMCID: PMC2497022 Caring for patients with type 2 diabetes — a responsibility to be shared between cardiologists and diabetologists: Munich, 30 August 2004 PMCID: PMC2497033 Satellite Sessions Bivalirudin, a new thrombin-specific anticoagulant in acute coronary syndromes and percutaneous coronary intervention: Munich, 28 August 2004 PMCID: PMC2497012 The endocannabinoid system: a new therapeutic target for multi-risk factor management: Munich, 30 August 2004 PMCID: PMC2497031 Revitalising medical options in the treatment of atrial fibrillation: Munich, 30 August 2004 PMCID: PMC2497020 From INSIGHT to ACTION — signposting the future of calcium antagonists in cardiovascular medicine: Munich, 30 August 2004 PMCID: PMC2497030 Reducing cardiovascular risk: dual inhibition for lipid management: Munich, 30 August 2004 PMCID: PMC2497029 Heart failure and the electrical prescription: Munich, 31 August 2004 PMCID: PMC2497027 The metabolic connection in cardiovascular risk: Munich, 31 August 2004 PMCID: PMC2497023 Endothelin receptor antagonism - improving outcomes in pulmonary arterial hypertension: Munich, 31 August 2004 PMCID: PMC2497011 Ebac Accredited Educational Programmes Statin therapy: setting new standards in the management of dyslipidaemia: Munich, 28 August 2004 PMCID: PMC2497016 If channels: a new target for the treatment of stable angina: Munich, 31 August 2004 PMCID: PMC2497026 Journal Matter Original table of contents page Administrative content — journal masthead, notices, indexes, etc. Advertisements | ||
